ArticleCardiovascular and interventional radiology2026
Percutaneous Recanalization of the Portal Vein in Children with Extrahepatic Portal Vein Obstruction.
Article in Cardiovascular and interventional radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Portal Vein Recanalization in Children: Expanding Physiological Restoration Beyond the Meso-Rex Bypass.Cardiovascular and interventional radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the feasibility, technical success, clinical outcomes, and safety of percutaneous portal vein recanalization (PVR) in children with extrahepatic portal vein obstruction (EHPVO). MATERIALS AND
methodsThis retrospective single-centre study included 20 consecutive paediatric patients (median age 8.86(5,9-10,9) years)who underwent 22 PVR attempts between April 2021 and January 2025. All patients presented with cavernous transformation of the portal vein confirmed by Doppler ultrasound and contrast-enhanced CT. Clinical manifestations included hypersplenism, gastrointestinal varices or bleeding and hepatopulmonary syndrome or encephalopathy. Transhepatic, transplenic, or combined approaches were used. Technical success was defined as achieving partial or complete PVR. Patients were followed by serial Doppler ultrasound and CT scans to assess vessel patency. Complications were classified according to the CIRSE system.
resultsTechnical success was achieved in 9 of 20 patients (45%). Complete portal vein recanalization was obtained in 5 patients, while partial recanalization involving only the right portal vein was achieved in 4. Median primary patency was 10,5 (1,8-18,3) months, with a primary assisted patency of 16 (1.8-26) months. No patient experienced recurrent gastrointestinal bleeding after successful recanalization. Complications included minor abdominal pain, perihepatic hematomas, bilio-portal fistulas, one intrahepatic thrombosis, and one biliary obstruction requiring hepaticojejunostomy.
conclusionPercutaneous portal vein recanalization is a feasible and minimally invasive option for paediatric patients with EHPVO, offering restoration of physiological portal flow and improvement of portal hypertension-related complications. Despite its technical complexity and need for multidisciplinary expertise, PVR may serve as an alternative to surgical approaches.
Indexed as
Identifiers
41673167What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.